Corporate Responsibility News

Corporate Responsibility News

Royalty Pharma Announces Pricing of $1.3 Billion of Senior Unsecured Notes, Including $600 Million Social Bond

NEW YORK, NY, July 15, 2021 – Royalty Pharma plc (Nasdaq: RPRX) announced today that it has priced an offering of $1.3 billion of senior unsecured notes, comprised of the following (collectively, the “Notes”): $600 million of 2.15% Senior Notes due 2031 (the “Social Bonds”)

Royalty Pharma Announces Charitable Gifts to Support COVID-19 Research at Leading Hospitals and Universities

NEW YORK, NY, December 22, 2020 – Royalty Pharma plc (Nasdaq: RPRX) today announced charitable contributions totaling $7,660,000 to support important COVID-19 research at The Rockefeller University, Mount Sinai Health System and Columbia University. This amount includes donations from Royalty

Royalty Pharma Donates $1,000,000 to Support Mount Sinai’s Covid-19 Patient Care and Clinical Research

NEW YORK, NY, December 21, 2020 – Royalty Pharma (Nasdaq: RPRX) today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System. The funds will be used to support: Mount Sinai’s Center for Post-COVID Care (CPCC) and Post-COVID Registry:   Royalty

Royalty Pharma and Pablo and Almudena Legorreta Support Development of Antibody Based Covid-19 Therapy at The Rockefeller University

NEW YORK, NY, December 17, 2020 – Royalty Pharma (Nasdaq: RPRX) and The Rockefeller University announced generous gifts totaling $5,760,000 from Royalty Pharma and Pablo and Almudena Legorreta. Half of the gift will be donated by Royalty Pharma and the other half by Pablo and Almudena Legorreta